ホーム > 商品詳細

近刊
丸善のおすすめ度

【精神科における減処方】

Deprescribing in Psychiatry '19

Gupta, Swapnil, Cahill, John, Miller, Rebecca  著

在庫状況 なし  お届け予定日 1ヶ月 
 刊行後の予定日となります
数量 冊 
価格 特価  \7,074(税込)         

発行年月 2019年09月
出版社/提供元
出版国 アメリカ合衆国
言語 英語
媒体 冊子
装丁 paper
ページ数/巻数 264 p.
ジャンル 洋書/生命科学・医学/神経・精神科学/神経・精神疾患
ISBN 9780190654818
商品コード 1030498096
本の性格 学術書
新刊案内掲載月 2019年07月
商品URL
参照
https://kw.maruzen.co.jp/ims/itemDetail.html?itmCd=1030498096

内容

The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term " refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits. Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour. As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.

カート

カートに商品は入っていません。